PL2178504T3 - Roztwór oczny na bazie prostagladyn bez środka konserwującego - Google Patents

Roztwór oczny na bazie prostagladyn bez środka konserwującego

Info

Publication number
PL2178504T3
PL2178504T3 PL08826597T PL08826597T PL2178504T3 PL 2178504 T3 PL2178504 T3 PL 2178504T3 PL 08826597 T PL08826597 T PL 08826597T PL 08826597 T PL08826597 T PL 08826597T PL 2178504 T3 PL2178504 T3 PL 2178504T3
Authority
PL
Poland
Prior art keywords
preservative
ophthalmic solution
based ophthalmic
prostaglandin
free prostaglandin
Prior art date
Application number
PL08826597T
Other languages
English (en)
Inventor
Frédéric Pilotaz
Fabrice Mercier
Henri Chibret
Original Assignee
Thea Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thea Lab filed Critical Thea Lab
Publication of PL2178504T3 publication Critical patent/PL2178504T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
    • A61K31/5575—Eicosanoids, e.g. leukotrienes or prostaglandins having a cyclopentane, e.g. prostaglandin E2, prostaglandin F2-alpha
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Ophthalmology & Optometry (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
PL08826597T 2007-07-20 2008-07-17 Roztwór oczny na bazie prostagladyn bez środka konserwującego PL2178504T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR0705272A FR2918891B1 (fr) 2007-07-20 2007-07-20 Solution ophtalmique a base de prostaglandines sans conservateur
EP08826597A EP2178504B1 (fr) 2007-07-20 2008-07-17 Solution ophtalmique à base de prostaglandines sans conservateur
PCT/FR2008/051347 WO2009013435A2 (fr) 2007-07-20 2008-07-17 Solution ophtalmique à base de prostaglandines sans conservateur

Publications (1)

Publication Number Publication Date
PL2178504T3 true PL2178504T3 (pl) 2011-06-30

Family

ID=39047927

Family Applications (1)

Application Number Title Priority Date Filing Date
PL08826597T PL2178504T3 (pl) 2007-07-20 2008-07-17 Roztwór oczny na bazie prostagladyn bez środka konserwującego

Country Status (9)

Country Link
US (1) US8772337B2 (pl)
EP (1) EP2178504B1 (pl)
AT (1) ATE493970T1 (pl)
DE (1) DE602008004356D1 (pl)
ES (1) ES2355018T3 (pl)
FR (1) FR2918891B1 (pl)
PL (1) PL2178504T3 (pl)
PT (1) PT2178504E (pl)
WO (1) WO2009013435A2 (pl)

Families Citing this family (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BRPI0818459A2 (pt) * 2007-10-16 2015-04-14 Sun Pharma Advanced Res Co Ltd Composição farmacêutica adequada para uso oftálmico.
EP2127638A1 (en) 2008-05-30 2009-12-02 Santen Pharmaceutical Co., Ltd Method and composition for treating ocular hypertension and glaucoma
BR112012023421B1 (pt) 2010-03-17 2021-09-14 Novaliq Gmbh Composição farmacêutica para tratamento de aumento de pressão intraocular
MX2012012941A (es) * 2010-05-07 2013-07-29 Sun Pharma Advanced Res Co Ltd Nuevas composiciones oftalmicas.
FR2961694B1 (fr) * 2010-06-29 2013-01-25 Thea Lab Systeme de delivrance polymerique d'une solution non visqueuse a base de prostaglandine sans conservateur
EP2598117A2 (en) * 2010-07-29 2013-06-05 Allergan, Inc. Preservative free bimatoprost solutions
WO2012015998A2 (en) * 2010-07-29 2012-02-02 Allergan, Inc. Preservative free bimatoprost and timolol solutions
US9061034B2 (en) * 2010-07-29 2015-06-23 Allergan, Inc. Preservative free bimatoprost and timolol solutions
EP2444063A1 (en) 2010-10-20 2012-04-25 Novaliq GmbH Liquid pharmaceutical compositions for the delivery of active ingredients
EP2452669A1 (en) 2010-10-29 2012-05-16 Omnivision GmbH Ophthalmic composition
EP2462921A1 (en) 2010-11-11 2012-06-13 Novaliq GmbH Liquid pharmaceutical compositions for the treatment of a posterior eye disease
WO2012141334A1 (en) * 2011-04-12 2012-10-18 R-Tech Ueno, Ltd. Aqueous ophthalmic composition
EA201301332A1 (ru) * 2011-05-27 2014-06-30 Рациофарм Гмбх ОФТАЛЬМОЛОГИЧЕСКИЙ ПРЕПАРАТ, СОДЕРЖАЩИЙ АНАЛОГ PGF2α
CA3142049C (en) 2012-09-12 2023-08-29 Novaliq Gmbh Semifluorinated alkane compositions
CA2997744C (en) 2012-09-12 2019-12-31 Novaliq Gmbh Compositions comprising mixtures of semifluorinated alkanes
IN2013MU02015A (pl) * 2013-06-13 2015-07-10 Cipla Ltd
EP3973954A1 (en) * 2013-10-15 2022-03-30 Pharmathen S.A. Preservative free pharmaceutical compositions for ophthalmic administration
GR1008330B (el) * 2013-10-17 2014-10-20 "Φαρματεν Α.Β.Ε.Ε.", Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση εχoν βελτιωμενες φυσικες ιδιοτητες και ογκο σταγονας
GR1008483B (el) * 2013-12-23 2015-05-12 Rafarm Α.Ε.Β.Ε., Οφθαλμικη φαρμακευτικη συνθεση και μεθοδος για την παρασκευη αυτης
CN105012231A (zh) * 2014-04-30 2015-11-04 四川科伦药物研究院有限公司 一种包含PGF2α衍生物的稳定性良好的眼用制剂及其制备方法
JP5893204B1 (ja) * 2015-02-23 2016-03-23 参天製薬株式会社 防腐効果のある医薬の組合せ
PL3103439T3 (pl) 2015-06-09 2019-12-31 Medproject Pharma-Entwicklungs- Und Vertriebsgesellschaft Mbh Zdolny do tworzenia kropli oftalmiczny żel bimatoprostu
DK3356313T3 (da) 2015-09-30 2020-07-20 Novaliq Gmbh 2-perfluorhexyloktan til oftalmisk indgivelse
WO2017055454A1 (en) 2015-09-30 2017-04-06 Novaliq Gmbh Semifluorinated compounds and their compositions
GR1008921B (el) * 2015-12-10 2017-01-12 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο σκευασμα ελευθερο συντηρητικου για οφθαλμικη χορηγηση περιεχον δεξαμεθαζονη
GR1009040B (el) 2016-04-19 2017-05-19 Φαρματεν Ανωνυμος Βιομηχανικη Και Εμπορικη Εταιρεια Φαρμακευτικων Ιατρικων Και Καλλυντικων Προϊοντων Φαρμακευτικο οφθαλμικο σκευασμα ελευθερο συντηρητικου
JP2019520357A (ja) 2016-06-23 2019-07-18 ノバリック ゲーエムベーハー 局所投与方法
WO2018038102A1 (en) * 2016-08-23 2018-03-01 Otsuka Pharmaceutical Co., Ltd. Ophthalmic pharmaceutical composition with improved preservative effectiveness or light stability
WO2018054932A1 (en) 2016-09-22 2018-03-29 Novaliq Gmbh Pharmaceutical compositions for use in the therapy of blepharitis
CN109906085B (zh) 2016-09-23 2024-03-08 诺瓦利克有限责任公司 含有环孢素的眼用组合物
KR101770324B1 (ko) 2016-11-09 2017-08-22 주식회사태준제약 안압 강하용 점안 조성물
PL3612228T3 (pl) 2017-04-21 2024-04-08 Dermaliq Therapeutics, Inc. Kompozycje jodu
US11278503B2 (en) 2017-05-12 2022-03-22 Novaliq Gmbh Pharmaceutical compositions comprising semifluorinated alkanes for the treatment of contact lense-related conditions
SG11202002640YA (en) 2017-09-27 2020-04-29 Novaliq Gmbh Ophthalmic compositions comprising latanoprost for use in the treatment of ocular diseases
US11896559B2 (en) 2017-10-04 2024-02-13 Novaliq Gmbh Opthalmic compositions comprising F6H8
CA3091308A1 (en) 2018-03-02 2019-09-06 Novaliq Gmbh Pharmaceutical compositions comprising nebivolol
WO2019206956A1 (en) 2018-04-27 2019-10-31 Novaliq Gmbh Ophthalmic compositions comprising tafluprost for the treatment of glaucoma
MA52258B1 (fr) 2018-07-12 2025-07-31 Nicox S.A. Compositions ophtalmiques contenant un prostamide libérant de l'oxyde nitrique
MY206642A (en) 2018-10-12 2024-12-30 Novaliq Gmbh Ophthalmic composition for treatment of dry eye disease
US12397039B2 (en) 2019-02-13 2025-08-26 Novaliq Gmbh Compositions and methods for the treatment of ocular neovascularization
MD3886799T2 (ro) 2019-08-07 2024-01-31 Aneira Pharma Inc Compoziții pentru tratamentul căderii părului
AU2020340561A1 (en) 2019-09-06 2022-03-31 Novaliq Gmbh Ophthalmic composition for the treatment of uveitis
US11400100B2 (en) 2019-12-11 2022-08-02 Somerset Therapeutics, Llc. Effective benzalkonium chloride-free bimatoprost ophthalmic compositions

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4431833A (en) * 1982-12-27 1984-02-14 American Cyanamid Company Prostaglandin and hydroxylated fatty acid ester formulations
HU207222B (en) * 1990-02-15 1993-03-29 Chinoin Gyogyszer Es Vegyeszet Process for producing eyedrops containing primycin
JP3480549B2 (ja) 1996-12-26 2003-12-22 参天製薬株式会社 ジフルオロプロスタグランジン誘導体およびその用途
US7074827B2 (en) 2002-10-24 2006-07-11 Sucampo Ag (Usa) Inc. Method for treating ocular hypertension and glaucoma
US20060199863A1 (en) 2003-07-31 2006-09-07 Santen Pharmaceutical Co., Ltd. Product containing prostaglandin
AR063111A1 (es) * 2007-10-03 2008-12-30 Eriochem Sa Una formulacion farmaceutica de taxano

Also Published As

Publication number Publication date
US8772337B2 (en) 2014-07-08
EP2178504B1 (fr) 2011-01-05
DE602008004356D1 (de) 2011-02-17
WO2009013435A2 (fr) 2009-01-29
US20100210720A1 (en) 2010-08-19
WO2009013435A3 (fr) 2009-03-12
ATE493970T1 (de) 2011-01-15
EP2178504A2 (fr) 2010-04-28
FR2918891B1 (fr) 2009-09-25
PT2178504E (pt) 2011-01-31
FR2918891A1 (fr) 2009-01-23
ES2355018T3 (es) 2011-03-22

Similar Documents

Publication Publication Date Title
PL2178504T3 (pl) Roztwór oczny na bazie prostagladyn bez środka konserwującego
AU2009296340B2 (en) Glyphosate formulations containing amidoalkylamine surfactants
CR20110043A (es) Mezclas fungicidas que comprenden 1-metilpirazol-4-ilcarboxanilidas sustituidas
MX2010002930A (es) Formulaciones que comprenden una composicion anti-microbiana.
MX2011008756A (es) Composicion insecticida que comprende un derivado de hidracida antranilica y un neonicotinoide.
MX2011008204A (es) Metodos para reducir la proliferacion y viabilidad de los agentes microbianos.
MY185280A (en) Parasiticidal compositions comprising an isoxazoline active agent, methods and uses thereof
MX338895B (es) Emulsiones de aceite en agua estabilizadas que incluyen ingredientes activos agricolamente.
CR11747A (es) Microemulsion mejorada que tiene un amplio rango de aplicacion
WO2007095258A3 (en) Rhamnolipid compositions and related methods of use
WO2007019554A3 (en) Polysaccharides for delivery of active agents
CR20110190A (es) Agente rodenticida sinérgico
AR053613A1 (es) Combinacion de compuestos activos fungicidas
EA201391463A1 (ru) Жидкая инсектицидная композиция
WO2007013666A3 (en) Anti-tumor agents comprising r-spondins
ECSP088476A (es) Combinación de productos activos fungicidas
WO2008068299A3 (en) Hydrobromide salt of an anti-hiv compound
TW200621160A (en) Anti-termite agent
MX2011008758A (es) Composicion insecticida que comprende un derivado de hidracida antranilica y un piretroide.
GT200600121A (es) Novedosos derivados de triazolopirimidina
WO2007121471A3 (en) Dialkyl ether delivery agents
WO2007065576A3 (de) Fungizide wirkstoffkombination
MX381609B (es) Composiciones pesticidas y metodos para controlar plagas de invertebrados.
WO2011069930A3 (en) Pesticidal mixtures
MX340428B (es) Alcoxilatos de cocoalquilpoliamina como agentes para composiciones herbicida de resistencia alta.